bioRxiv Science⌕ Search

Biology subjects

Kraut, R.

Publications and source records attributed to Kraut, R..

2 recordsLinked to original sources

Toxin-glycolipid interactions measured by imaging surface plasmon resonance on artificial membranes predicts diffusion behavior and lipid dependence of binding to cells

Membrane-protein interactions mediate cellular invasion by toxins, and are thought to involve organized plasma membrane lipid domains, often containing glycolipids, other sphingolipids, and/or cholesterol. Here, we characterize an isolated glycolipid-interacting domain of the tetanus toxin heavy chain (Hc) as a fluorescently labelled peptide, TeNT46, and describe its membrane dynamics and binding characteristics on artificial bilayers and cellular membranes. We show that this novel ganglioside-interacting probe TeNT46 retains the glycolipid binding preferences of the parent toxin, using imaging-SPR (iSPR) on a micro-patterned hybrid bilayer surface. On live cell membranes, using fluorescence correlation spectroscopic (FCS) diffusion measurements to compare TeNT46 to the well-studied GM1-binding toxin CTxB, we find that both probes display ordered domain-binding characteristics, but distinct cholesterol and sphingolipid dependencies. Strikingly, the contrasting lipid requirements of TeNT46 from those of CTxB in cells are predicted by their iSPR binding preferences on hybrid synthetic membranes. Based on the combined findings from iSPR and FCS, we propose a model for toxin-membrane interaction whereby a unique lipid constellation determines optimum binding for each probe independently of lateral confinement, which is more generally imposed by cholesterol. Our resulting understanding of the specific lipid requirements of these toxin targets and their dynamics in cell membranes could be important for the future design of preventive membrane-based nano-decoys and cell-delivery tools.

cell biology↗

Drosophila BEACH domain autophagic adaptor blue cheese shuttles between vesicle populations and is required for an early step in autophagy

Drosophila melanogaster blue cheese (bchs) encodes a large BEACH (Beige and Chediak-Higashi) family protein that is postulated to function as an adaptor protein with roles in vesicle trafficking. Mutation in bchs leads to the accumulation of ubiquitinated aggregates in aged brains, presumably because of a conserved function with its human homologue Autophagy-Linked FYVE (ALFY), which interacts with Atg5 and p62 to promote the clearance of aggregate-prone proteins. In this study, we present pharmacological and genetic evidence using a well-defined larval motorneuron paradigm that in Drosophila bchs mutants, autophagic deficit contributes to neurodegeneration. Specifically, we show that motorneuron death in larvae is accompanied by the accumulation of prominent ubiquitinated aggregates in synaptic termini, and that these are sensitive to autophagy modulating drugs. In primary bchs neurons, early autophagic compartments increase in number and intensity based on Atg5 expression, but fail to progress to Atg8-labelled compartments, indicating non-clearance. A rescuing transgene encoding the longest Bchs BEACH domain isoform not only reverses this defect, but also greatly increases Atg8 compartment number and rescues neuronal death. Although only a small fraction of Bchs colocalizes with these markers under wild-type conditions, the population of Bchs that does associate with autophagosomes shuttles between different locations depending on how autophagy is induced. These observations, together with epistatic relationships between bchs mutant alleles and autophagy-modulating drugs and genetic backgrounds, points to a model whereby BEACH domain isoforms of Bchs participate in the early steps of autophagy by recruiting Atg5 to target substrates for clearance, and that Bchs association with different parts of the autophagy machinery depends upon the type of autophagic stress imposed upon the neuron.

cell biology↗